Outcomes Of Talazoparib (Tala) Versus Physician'S Choice Of Chemotherapy (Pct) In Patients (Pts) With Advanced Breast Cancer (Abc) And A Germline Brca (Gbrca) Mutation By Line Of Chemotherapy (Ct) In The Embraca Trial